Clinical Research Directory

Infrared Photobiomodulation in Humans With Epilepsy

Sponsor: Beth Israel Deaconess Medical Center

Summary

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.

Official title: An Open Label Pilot Study of Infrared Photobiomodulation in Humans With Epilepsy

Key Details

Conditions

Interventions

Locations (1)